Structures by: Krishnakumar R. V.
Total: 109
Ethyl 6'-cyano-7'-(<i>p</i>-tolyl)-1',6',7',7a'-tetrahydro-3'<i>H</i>-spiro[indeno[1,2-<i>b</i>]quinoxaline-11,5'-pyrrolo[1,2-<i>c</i>]thiazole]-6'-carboxylate
C31H26N4O2S
IUCrData (2019) 4, 1 x190010
a=10.5467(17)Å b=11.6469(19)Å c=12.942(2)Å
α=108.321(3)° β=102.108(3)° γ=110.887(3)°
6'-(3-Bromophenyl)-7'-nitro-1',6',7',7a'-tetrahydro-3'<i>H</i>-spiro[indeno[1,2-<i>b</i>]quinoxaline-11,5'-pyrrolo[1,2-<i>c</i>]thiazole]
C26H19BrN4O2S
IUCrData (2018) 3, 2 x180238
a=25.289(5)Å b=10.076(2)Å c=19.050(4)Å
α=90.00(3)° β=98.89(3)° γ=90.00(3)°
Ethyl 6'-cyano-7'-phenyl-1',6',7',7a'-tetrahydro-3'<i>H</i>-spiro[indeno[1,2-<i>b</i>]quinoxaline-11,5'-pyrrolo[1,2-<i>c</i>]thiazole-6'-carboxylate
C30H24N4O2S
IUCrData (2018) 3, 9 x181286
a=18.6131(13)Å b=18.2243(13)Å c=15.8867(11)Å
α=90° β=110.7570(10)° γ=90°
2-[(4-Chlorophenyl)(2-phenyl-1<i>H</i>-indol-3-yl)methyl]cyclohexan-1-one
C27H24ClNO
IUCrData (2016) 1, 4 x160644
a=7.2562(2)Å b=16.4818(5)Å c=18.0306(6)Å
α=90° β=95.149(2)° γ=90°
9-Fluoro-2,4,4a,6-tetrahydrospiro[benzo[<i>c</i>]chromene-3,2'-[1,3]dioxolane]
C15H15FO3
IUCrData (2017) 2, 1 x170045
a=7.0373(4)Å b=20.7068(14)Å c=8.4725(6)Å
α=90° β=92.088(3)° γ=90°
Diethyl 1-(4-chlorobenzyl)-4-(4-chlorophenyl)-2,2-dioxo-3,4,6,7,8,8a-hexahydro-1<i>H</i>-pyrrolo[2,1-<i>c</i>][1,4]thiazine-1,3-dicarboxylate
C26H29Cl2NO6S
Acta Crystallographica Section E (2018) 74, 9 1267-1271
a=11.6596(4)Å b=14.5734(4)Å c=15.7000(5)Å
α=90° β=104.635(2)° γ=90°
Diethyl 1-(4-methylbenzyl)-4-(4-methylphenyl)-2,2-dioxo-3,4,6,7,8,8a-hexahydro-1<i>H</i>-pyrrolo[2,1-<i>c</i>][1,4]thiazine-1,3-dicarboxylate
C28H35NO6S
Acta Crystallographica Section E (2018) 74, 9 1267-1271
a=11.8641(5)Å b=14.4765(6)Å c=15.8654(7)Å
α=90° β=104.960(2)° γ=90°
2'-(4-Bromobenzoyl)-1'-(2-chlorophenyl)-1,1',2,2',5',6',7',7a'-octahydrospiro[indole-3,3'-pyrrolizin]-2-one
C27H22BrClN2O2
Acta Crystallographica Section E (2016) 72, 11 1637-1641
a=10.7280(4)Å b=9.7793(4)Å c=22.6746(9)Å
α=90° β=98.9720(10)° γ=90°
2'-Benzoyl-1'-(4-methylphenyl)-1,1',2,2',5',6',7',7a'-octahydrospiro[indole-3,3'-pyrrolizin]-2-one
C28H26N2O2
Acta Crystallographica Section E (2016) 72, 11 1637-1641
a=36.030(2)Å b=24.2248(16)Å c=10.1301(6)Å
α=90° β=90° γ=90°
<i>trans</i>-Bis[μ-2-(1,3-benzothiazol-2-yl)phenolato]-κ^3^<i>N</i>,<i>O</i>:<i>O</i>;κ^3^<i>O</i>:<i>N</i>,<i>O</i>-bis[<i>fac</i>-tricarbonylrhenium(I)]
C32H16N2O8Re2S2
Acta Crystallographica Section E (2017) 73, 2 310-313
a=8.9250(11)Å b=9.7342(12)Å c=10.0844(12)Å
α=66.438(5)° β=75.636(5)° γ=63.585(5)°
<i>cis</i>-Bis[μ-2-(1,3-benzothiazol-2-yl)phenolato]-κ^3^<i>N</i>,<i>O</i>:<i>O</i>;κ^3^<i>O</i>:<i>N</i>,<i>O</i>-bis[<i>fac</i>-tricarbonylrhenium(I)]
C32H16N2O8Re2S2
Acta Crystallographica Section E (2017) 73, 2 310-313
a=16.1480(7)Å b=11.6519(5)Å c=15.6329(8)Å
α=90° β=90° γ=90°
5''-(2-Chlorobenzylidene)-4'-(2-chlorophenyl)-1'-methyldispiro[acenaphthene-1,2'-pyrrolidine-3',3''-piperidine]-2,4''-dione
C34H28Cl2N2O2
Acta Crystallographica Section E (2019) 75, 10 1456-1462
a=8.6710(4)Å b=15.6756(7)Å c=20.2284(9)Å
α=90° β=93.036(2)° γ=90°
2-Hydroxy-2-(2-oxocycloheptyl)-2,3-dihydro-1<i>H</i>-indene-1,3-dione
C16H16O4
Acta Crystallographica Section E (2015) 71, 10 o715-o716
a=7.4131(5)Å b=18.8596(13)Å c=19.0166(13)Å
α=90° β=90° γ=90°
N-(β-Carboxyethyl)-α-isoleucine
C9H18N2O3
Acta Crystallographica Section E (2015) 71, 9 o665-o666
a=5.2996(5)Å b=9.0053(7)Å c=23.211(2)Å
α=90° β=90° γ=90°
5-Benzoyl-2,4-diphenyl-4,5-dihydrofuran-3-carbonitrile
C24H17NO2
Acta Crystallographica Section E (2015) 71, 9 o663-o664
a=10.0704(7)Å b=15.7994(12)Å c=11.8632(9)Å
α=90° β=98.886(3)° γ=90°
DL-phenylalaninium trichloroacetate
C9H12NO2,C2Cl3O2
Acta Crystallographica Section E (2005) 61, 2 o203-o205
a=18.838(3)Å b=16.557(2)Å c=10.065(12)Å
α=90.00° β=111.354(14)° γ=90.00°
2,6-Bis(2-methoxyphenyl)-1-nitroso-3,5-diphenylpiperidin-4-one
C31H28N2O4
Acta Crystallographica Section E (2005) 61, 9 o3050-o3052
a=13.4969(3)Å b=11.7546(3)Å c=16.1467(4)Å
α=90.00° β=97.8420(10)° γ=90.00°
Dichloro(β-alanine)cadmium(II)
C3H7CdCl2NO2
Acta Crystallographica Section E (2002) 58, 6 m307-m309
a=6.9391(10)Å b=12.945(2)Å c=7.9714(10)Å
α=90.00° β=90.00° γ=90.00°
2,2'-thiobis(2-benzoyl-3-(4-chlorophenyl)oxirane)
C30H20Cl2O4S
Acta Crystallographica Section E (2002) 58, 5 o504-o505
a=14.0724(17)Å b=16.3184(16)Å c=11.768(3)Å
α=90.00° β=103.66(2)° γ=90.00°
2,2'-Sulfonylbis(2-benzoyl-3-phenyloxirane)
C30H22O6S
Acta Crystallographica Section E (2002) 58, 10 o1174-o1176
a=13.228(3)Å b=11.754(6)Å c=18.659(5)Å
α=90.00° β=119.05(2)° γ=90.00°
Bis(1,3-diphenylpropane-1,3-dionato-O,O')(aqua)(benzo-15-crown-5) dioxo-uranium(VI)
C30H24O7U,C14H20O5
Acta Crystallographica Section E (2002) 58, 7 m316-m318
a=9.210(2)Å b=12.121(2)Å c=19.374(9)Å
α=73.59(2)° β=81.20(2)° γ=81.890(10)°
DL-aspartic acid hemioxalate
2(C4H8NO41),C2O42
Acta Crystallographica Section E (2003) 59, 2 o108-o110
a=7.3870(10)Å b=5.4770(10)Å c=18.522(3)Å
α=90.0° β=99.360(10)° γ=90.0°
Prolinium trichloroacetate
C5H10NO21,C2Cl3O21
Acta Crystallographica Section E (2003) 59, 3 o277-o279
a=9.7541(14)Å b=9.7541(14)Å c=10.089(2)Å
α=90.00° β=90.00° γ=120.00°
Trichloroacetic acid
C2HCl3O2
Acta Crystallographica Section E (2003) 59, 3 o316-o318
a=6.1260(10)Å b=9.5730(10)Å c=11.2430(10)Å
α=90.00° β=119.23(2)° γ=90.00°
Methioninium trichloroacetate
C5H12NO2S1,C2Cl3O21
Acta Crystallographica Section E (2003) 59, 1 o31-o33
a=6.1359(12)Å b=8.9746(18)Å c=12.731(3)Å
α=70.54(3)° β=85.95(3)° γ=85.08(3)°
DL-phenylalaninium maleate
C9H12NO21,C4H3O41
Acta Crystallographica Section E (2003) 59, 2 o209-o211
a=12.308(3)Å b=5.9942(12)Å c=18.061(4)Å
α=90.00° β=99.15(3)° γ=90.00°
DL-valine hemifumaric acid
2(C5H11NO2),C4H4O4
Acta Crystallographica Section E (2003) 59, 6 o857-o859
a=24.417(4)Å b=7.5713(10)Å c=10.013(2)Å
α=90.00° β=109.268(10)° γ=90.00°
Pyridinuim oxalate oxalic acid dihydrate
C5H6N1,C2H2O41,C2HO4,2H2O
Acta Crystallographica Section E (2003) 59, 6 o742-o744
a=6.992(7)Å b=9.539(2)Å c=10.098(2)Å
α=84.36(2)° β=79.54(4)° γ=74.71(6)°
DL-Valine--succinic acid (2/1)
2C5H11NO2,C4H6O4
Acta Crystallographica Section E (2004) 60, 6 o1009-o1011
a=24.373(2)Å b=7.5744(6)Å c=10.0284(9)Å
α=90.00° β=106.134(2)° γ=90.00°
(Dibenzylacetone-κO)(1,3-diphenylpropane-1,3-dionato- κ^2^O,O)dioxouranium(VI)
C47H36O7U
Acta Crystallographica Section E (2004) 60, 6 m773-m775
a=13.001(3)Å b=23.211(3)Å c=27.010(8)Å
α=90.00° β=90.00° γ=90.00°
2,6-Bis(4-methoxyphenyl)-1-nitroso-3,5-diphenylpiperidin-4-one
C31H28N2O4
Acta Crystallographica Section E (2005) 61, 2 o359-o361
a=10.8364(8)Å b=19.4649(15)Å c=12.6722(10)Å
α=90.00° β=103.9260(10)° γ=90.00°
4,8,9,10-Tetra(4-methoxyphenyl)-1,3-diazaadamantan-6-one-benzene solvate
C36H36N2O5,C6H6
Acta Crystallographica Section E (2001) 57, 4 o305-o306
a=16.6240(5)Å b=26.0007(16)Å c=8.2207(7)Å
α=90.00° β=90.00° γ=90.00°
DL-valinium trichloroacetate
C5H12NO21,C2Cl3O21
Acta Crystallographica Section E (2002) 58, 3 o279-o281
a=7.2380(14)Å b=8.4150(17)Å c=10.303(2)Å
α=106.50(3)° β=97.50(3)° γ=95.80(3)°
Dichlorobis(DL-alanine)zinc(II)
C6H14Cl2N2O4Zn
Acta Crystallographica Section E (2002) 58, 3 m127-m129
a=9.996(5)Å b=13.622(4)Å c=8.616(3)Å
α=90.00° β=90.300(10)° γ=90.00°
Β-alaninum oxalate hemihydrate
C3H8NO21,C2HO41,0.5H2O
Acta Crystallographica Section E (2002) 58, 2 o117-o119
a=22.373(3)Å b=5.6925(7)Å c=14.917(3)Å
α=90.00° β=115.310(10)° γ=90.00°
C3H8NO32,C2O42,2H2O
C3H8NO32,C2O42,2H2O
Acta Crystallographica Section E (2002) 58, 2 o114-o116
a=4.8685(10)Å b=17.199(7)Å c=17.172(4)Å
α=90.00° β=91.678(19)° γ=90.00°
Sarcosinium maleate
C3H8NO21,C4H3O41
Acta Crystallographica Section E (2002) 58, 5 o478-o480
a=22.784(5)Å b=5.9117(12)Å c=13.788(3)Å
α=90.00° β=96.69(3)° γ=90.00°
4,8,9,10-Tetraphenyl-1,3-diazaadamantan-6-one
C32H28N2O
Acta Crystallographica Section E (2002) 58, 6 o675-o677
a=11.7347(14)Å b=11.6976(13)Å c=17.6391(14)Å
α=90.00° β=94.320(10)° γ=90.00°
L-alaninium tartrate
C3H8NO21,C4H5O61
Acta Crystallographica Section E (2002) 58, 11 o1306-o1308
a=5.1446(8)Å b=13.721(3)Å c=7.4751(9)Å
α=90.000(10)° β=98.090(10)° γ=90.000(10)°
DL-methioninium maleate
C5H12NO2S1,C4H3O41
Acta Crystallographica Section E (2002) 58, 4 o396-o398
a=11.070(2)Å b=5.746(5)Å c=19.697(14)Å
α=90.00(7)° β=102.34(3)° γ=90.00(4)°
4,8,9,10-Tetraphenyl-1,3-diazaadamantan-6-one acetone solvate
2C32H28N2O,C3H6O
Acta Crystallographica Section E (2002) 58, 11 o1210-o1212
a=12.6087(14)Å b=13.7214(12)Å c=17.056(2)Å
α=92.760(10)° β=103.570(10)° γ=111.600(10)°
Β-alaninium trichloroacetate
C3H8NO21,C2Cl3O21
Acta Crystallographica Section E (2003) 59, 2 o206-o208
a=6.8049(14)Å b=21.100(4)Å c=6.8968(14)Å
α=90.00° β=95.75(3)° γ=90.00°
L-Leucinium oxalate
C6H14NO21,C2HO41
Acta Crystallographica Section E (2003) 59, 6 o878-o880
a=5.674(3)Å b=9.803(9)Å c=9.906(8)Å
α=87.37(7)° β=99.64(5)° γ=100.35(6)°
2,6-bis-4-(methylphenyl)-3-phenyl-pipridin-4-one
C25H25NO
Acta Crystallographica Section E (2003) 59, 10 o1538-o1540
a=15.214(3)Å b=8.7408(17)Å c=14.885(3)Å
α=90.00° β=90.75(3)° γ=90.00°
C9H11NO2,C4H4O4
C9H11NO2,C4H4O4
Acta Crystallographica Section E (2003) 59, 7 o952-o954
a=5.7016(10)Å b=11.4864(15)Å c=11.5542(17)Å
α=67.953(11)° β=81.158(13)° γ=79.379(15)°
L-Histidinium hemihydrochloride tartrate tartaric acid dihydrate
C6H10N3O21,C4H5O61,0.5HCl,C4H6O6,2H2O
Acta Crystallographica Section E (2003) 59, 7 o955-o958
a=35.857(6)Å b=7.4806(8)Å c=7.6783(12)Å
α=90.00° β=93.192(18)° γ=90.00°
Trans-3-Acetyl-5-benzoyl-2-methyl-4-phenyl-4,5-dihydrofuran
C20H18O3
Acta Crystallographica Section E (2003) 59, 9 o1321-o1323
a=9.846(2)Å b=10.564(2)Å c=16.340(3)Å
α=90.00° β=113.023(2)° γ=90.00°
1-Acetyl-5-(2-methoxyphenyl)-3-(2-methoxystyryl)-2-pyrazoline
C21H22N2O3
Acta Crystallographica Section E (2004) 60, 4 o476-o478
a=8.8485(11)Å b=8.9259(7)Å c=12.9652(15)Å
α=70.074(9)° β=81.597(10)° γ=75.041(8)°
L-Phenylalaninium malonate L-phenylalanine
C9H12NO2,C3H3O4,C9H11NO2
Acta Crystallographica Section E (2005) 61, 4 o992-o994
a=14.031(3)Å b=5.5082(10)Å c=14.601(3)Å
α=90.00° β=107.412(3)° γ=90.00°
4-Oxo-2,3,5,6-tetraphenylpiperidine-1-carbonitrile ethyl acetate hemisolvate
C30H24N2O,0.5C4H8O2
Acta Crystallographica Section E (2006) 62, 4 o1295-o1297
a=9.3887(3)Å b=10.6241(4)Å c=26.7247(10)Å
α=90.00° β=92.232(2)° γ=90.00°
L-argininium trifluoroacetic acid
C6H15N4O2,C2F3O2
Acta Crystallographica Section E (2006) 62, 7 o3127-o3129
a=10.5860(6)Å b=5.6880(4)Å c=10.8780(7)Å
α=90.0° β=106.7700(10)° γ=90.0°
4,8,9,10-Tetrakis(4-chlorophenyl)-1,3-diazaadamantan-6-one
C32H24Cl4N2O
Acta Crystallographica Section E (2001) 57, 9 o860-o862
a=6.818(3)Å b=13.288(4)Å c=30.670(14)Å
α=90.00° β=94.47(3)° γ=90.00°
DL-alaninium oxalate
C3H8NO21,C2HO41
Acta Crystallographica Section E (2001) 57, 8 o666-o668
a=5.662(2)Å b=7.342(2)Å c=19.157(6)Å
α=90.00° β=94.48(3)° γ=90.00°
DL-threoninium oxalate
C4H10NO31,C2HO41
Acta Crystallographica Section E (2001) 57, 8 o769-o771
a=8.325(5)Å b=10.957(4)Å c=10.363(4)Å
α=90.00° β=112.39(5)° γ=90.00°
L-alaninium oxalate
C3H8N1O21,C2H1O41
Acta Crystallographica Section E (2001) 57, 7 o633-o635
a=5.6304(15)Å b=7.2353(15)Å c=19.597(3)Å
α=90.00° β=90.00° γ=90.00°
L-alaninium maleate
C3H8O2N1,C4H3O41
Acta Crystallographica Section E (2001) 57, 9 o855-o857
a=5.5873(11)Å b=7.3864(17)Å c=23.688(3)Å
α=90.00° β=90.00° γ=90.00°
C3H8NO21,C4H3O41
C3H8NO21,C4H3O41
Acta Crystallographica Section E (2001) 57, 10 o922-o924
a=5.4186(11)Å b=22.951(5)Å c=7.4518(15)Å
α=90.000(17)° β=99.730(16)° γ=90.000(18)°
L-phenylalaninium maleate
C9H12NO21,C4H3O41
Acta Crystallographica Section E (2001) 57, 10 o968-o970
a=11.0560(9)Å b=5.3326(4)Å c=11.4712(7)Å
α=90.000(10)° β=101.070(10)° γ=90.000(10)°
Dichlorobis(sarcosinato)zinc(II)
C6H14Cl2N2O4Zn
Acta Crystallographica Section E (2001) 57, 10 m435-m437
a=14.191(2)Å b=10.6550(10)Å c=15.917(2)Å
α=90.00° β=90.00° γ=90.00°
DL-valinium maleate
C5H12NO21,C4H3O41
Acta Crystallographica Section E (2001) 57, 11 o1102-o1104
a=6.1830(12)Å b=9.6480(19)Å c=10.534(2)Å
α=104.92(3)° β=106.32(3)° γ=104.40(3)°
Dichlorobis(DL-valine)zinc(II)
C10H22Cl2N2O4Zn
Acta Crystallographica Section E (2001) 57, 11 m498-m500
a=19.997(2)Å b=6.2259(10)Å c=13.5028(10)Å
α=90.00° β=103.02(2)° γ=90.00°
Glycinium maleate
CH6NO21,C5H3O41
Acta Crystallographica Section E (2001) 57, 8 o751-o753
a=17.689(4)Å b=5.6610(11)Å c=17.328(4)Å
α=90.00° β=112.30(3)° γ=90.00°
Trichloro(sarcosinium) zinc(II) monohydrate
C3H8Cl3N1O2Zn,H2O1
Acta Crystallographica Section E (2001) 57, 5 m192-m194
a=6.6181(12)Å b=7.4989(11)Å c=9.900(4)Å
α=90.00° β=92.62(2)° γ=90.00°
2,6-Bis(2-methylphenyl)-1-nitroso-3,5-diphenylpiperidin-4-one
C31H28N2O2
Acta Crystallographica Section E (2005) 61, 8 o2458-o2460
a=10.7715(4)Å b=11.0565(4)Å c=20.9841(7)Å
α=90.00° β=101.121(2)° γ=90.00°
Pyridinium tartrate
C5H6N,C4H5O6
Acta Crystallographica Section E (2006) 62, 8 o3220-o3222
a=5.0390(13)Å b=13.220(2)Å c=15.318(2)Å
α=90.0° β=90.0° γ=90.0°
L-Phenylalanine benzoic acid solvate
C9H11NO2,C7H6O2
Acta Crystallographica Section E (2005) 61, 11 o3625-o3627
a=5.419(2)Å b=7.438(2)Å c=17.814(3)Å
α=90.00° β=92.94(2)° γ=90.00°
Phenylalaninium trichloroacetate
2C9H12NO21,2C2Cl3O21,H2O
Acta Crystallographica Section E (2003) 59, 7 o1084-o1086
a=19.675(3)Å b=6.1150(10)Å c=26.584(2)Å
α=90.00° β=109.60(10)° γ=90.00°
Bis(DL-alanine)tetraaquacobalt(II) dinitrate
C6H22CoN2O8,2NO3
Acta Crystallographica Section E (2003) 59, 8 m562-m564
a=5.5021(6)Å b=6.6396(8)Å c=23.821(3)Å
α=90.00° β=96.220(10)° γ=90.00°
Bis(1,3-diphenylpropane-1,3-dionato-κ^2^O,O)dioxo(triphenylphosphine oxide-κO)uranium(VI)
C48H37O7PU
Acta Crystallographica Section E (2003) 59, 7 m524-m526
a=18.345(2)Å b=11.022(4)Å c=20.924(4)Å
α=90.00° β=103.170(13)° γ=90.00°
Catena-Poly[[dicadmium(II)]-μ-DL-alanine-di-μ-chloro-monohydrato]
C3H7CdCl2NO2,H2O
Acta Crystallographica Section E (2003) 59, 9 m756-m758
a=7.1190(15)Å b=14.408(3)Å c=8.6396(13)Å
α=90.00° β=107.98(2)° γ=90.00°
Ethyl cis-3-(2-methoxyphenyl)-1-4-thiazine-2-carboxylate 1,1-dioxide
C14H19NO5S
Acta Crystallographica Section E (2003) 59, 9 o1400-o1402
a=25.706(5)Å b=9.7180(19)Å c=12.245(2)Å
α=90.00° β=93.44(3)° γ=90.00°
L-Threoninium trichloroacetate
C4H10NO3,C2Cl3O2
Acta Crystallographica, Section E (2004) 60, 8 o1354-o1356
a=10.3290(11)Å b=10.4271(11)Å c=10.7795(11)Å
α=90.00° β=103.115(12)° γ=90.00°
2,6-Bis(2-chlorophenyl)-1-nitroso-3,5-diphenylpiperidin-4-one
C29H22Cl2N2O2
Acta Crystallographica Section E (2005) 61, 10 o3391-o3393
a=10.5812(3)Å b=12.9766(4)Å c=17.5935(5)Å
α=90.00° β=95.8630(10)° γ=90.00°
C19H18N2O
C19H18N2O
Acta Crystallographica Section C (1998) 54, 7 976-978
a=12.704(2)Å b=15.788(4)Å c=16.676(2)Å
α=90.00° β=107.700(10)° γ=90.00°
C5H11NO7
C5H11NO7
Acta Crystallographica Section C (1998) 54, 12 IUC9800063
a=5.5806(7)Å b=22.641(3)Å c=7.0249(3)Å
α=90.000(10)° β=99.790(10)° γ=90.000(10)°
1-acetyl-5-(2-chlorophenyl)-3-(2-chlorostyryl)-2-pyrazoline
C19H16Cl2N2O
Acta Crystallographica Section C (1999) 55, 6 987-990
a=9.296(2)Å b=10.524(3)Å c=11.044(3)Å
α=113.89(2)° β=100.15(2)° γ=109.75(2)°
1-acetyl-5-(4-methoxyphenyl)-3-(4-methoxystyryl)-2-pyrazoline
C21H22N2O3
Acta Crystallographica Section C (1999) 55, 6 987-990
a=5.7200(10)Å b=12.085(4)Å c=26.654(4)Å
α=90.00° β=91.78(2)° γ=90.00°
Poly[triaquatri-μ-hippurato-hippuratodibarium]
C18H19BaN2O7.5
Acta Crystallographica Section E (2007) 63, 5 m1408-m1410
a=8.6447(7)Å b=11.0825(4)Å c=21.0332(9)Å
α=75.974(8)° β=88.987(9)° γ=84.435(6)°
3,5-Bis(4-methylbenzylidene)-4-oxopiperidine-1-carbonitrile
C22H20N2O
Acta Crystallographica Section E (2007) 63, 9 o3749-o3749
a=9.1976(2)Å b=9.5012(2)Å c=10.9418(3)Å
α=104.03(2)° β=95.0800(10)° γ=108.730(10)°
1-(4-Chlorophenyl)-8-(4-fluorophenyl)-4-[(<i>E</i>)-(4- fluorophenyl)methylidene]-6-methyl-4,5,6,7,7a,8-hexahydro- 1,2,4-oxadiazolo[5,4-<i>d</i>]pyrido[3,4-<i>c</i>][1,5]benzothiazepine
C33H26ClF2N3OS
Acta Crystallographica Section E (2007) 63, 11 o4268-o4268
a=10.836(5)Å b=11.366(4)Å c=23.100(3)Å
α=90.0° β=92.630(10)° γ=90.0°
8-[(<i>E</i>)-4-Methoxybenzylidene]-4-(4-Methoxyphenyl)-3- (3-phenyl-1,2,4-oxadiazol-5-yl)-5,6,7,8-tetrahydro-4<i>H</i>-chromen-2-amine
C32H29N3O4
Acta Crystallographica Section E (2007) 63, 9 o3750-o3750
a=10.5014(3)Å b=11.3187(4)Å c=11.6458(4)Å
α=91.07(2)° β=98.45(2)° γ=104.10(3)°
DL-alanine
C3H7NO2
Acta Crystallographica Section C (2001) 57, 5 614-615
a=12.0263(17)Å b=6.0321(9)Å c=5.829(2)Å
α=90.00(12)° β=90.00(3)° γ=90.00(3)°
[3-Methyl-4-(4-methylphenyl)-1-phenyl-6-trifluoromethyl-1<i>H</i>-pyrazolo[3,4-<i>b</i>]pyridin-5-yl](thiophen-2-yl)methanone
C26H18F3N3OS
Acta Crystallographica Section C (2013) 69, 4 412-415
a=10.0323(4)Å b=10.3715(5)Å c=11.7411(5)Å
α=109.211(2)° β=96.105(2)° γ=95.676(2)°
[4-(4-Chlorophenyl)-3-methyl-1-phenyl-6-trifluoromethyl-1<i>H</i>-pyrazolo[3,4-<i>b</i>]pyridin-5-yl](thiophen-2-yl)methanone
C25H15ClF3N3OS
Acta Crystallographica Section C (2013) 69, 4 412-415
a=10.0018(7)Å b=10.3503(8)Å c=11.6309(10)Å
α=108.607(4)° β=95.295(4)° γ=95.628(4)°
L-prolinium tartrate
C5H10NO2,C4H5O6
Acta Crystallographica Section C (2001) 57, 4 423-424
a=5.0070(10)Å b=17.676(3)Å c=6.5230(10)Å
α=90° β=100.40(2)° γ=90°
(9-Fluoro-4<i>H</i>-chromeno[4,3-<i>c</i>]isoxazol-3-yl)methanol
C11H8FNO3
Acta Crystallographica Section C (2012) 68, 8 o288-o293
a=14.1516(2)Å b=7.00640(10)Å c=18.3134(2)Å
α=90.00° β=90.00° γ=90.00°
(9-Chloro-4<i>H</i>-chromeno[4,3-<i>c</i>]isoxazol-3-yl)methanol
C11H8ClNO3
Acta Crystallographica Section C (2012) 68, 8 o288-o293
a=9.43060(10)Å b=14.8892(2)Å c=21.4949(2)Å
α=98.7640(10)° β=97.6100(10)° γ=94.0130(10)°
Glycinium oxalate
C2H6NO2,C2HO4
Acta Crystallographica Section C (2001) 57, 1 115-116
a=10.5807(15)Å b=5.650(2)Å c=12.093(3)Å
α=90.00(3)° β=113.830(10)° γ=90.00(2)°
Sarcosinium tartrate
C3H8NO21,C4H5O61
Acta Crystallographica Section C (2001) 57, 2 165-166
a=5.0038(15)Å b=6.442(2)Å c=8.3179(11)Å
α=78.60(2)° β=80.62(2)° γ=79.80(2)°
(4<i>H</i>-Chromeno[4,3-<i>c</i>]isoxazol-3-yl)methanol
C11H9NO3
Acta Crystallographica Section C (2012) 68, 11 o481-o484
a=9.6423(2)Å b=8.34060(10)Å c=13.1461(2)Å
α=90.00° β=121.2180(10)° γ=90.00°
(8-Methyl-4<i>H</i>-chromeno[4,3-<i>c</i>]isoxazol-3-yl)methanol monohydrate
C12H11NO3,H2O
Acta Crystallographica Section C (2012) 68, 11 o481-o484
a=31.2492(5)Å b=4.67140(10)Å c=17.3083(4)Å
α=90.00° β=121.030(2)° γ=90.00°
1-Acetylpyrrolidine-2-carboxylic acid monohydrate
C7H11NO3,H2O
Acta Crystallographica Section C (2013) 69, 11 1390-1396
a=6.2876(3)Å b=10.7132(5)Å c=6.7764(3)Å
α=90.00° β=111.1430(10)° γ=90.00°
<i>N</i>-Benzyl-<i>L</i>-proline
C12H15NO2
Acta Crystallographica Section C (2013) 69, 11 1390-1396
a=8.7552(7)Å b=10.6254(8)Å c=11.2816(8)Å
α=90.00° β=93.737(2)° γ=90.00°
2,6-diphenyl-thiopyran-4-one
C17H16OS
Acta Crystallographica Section C (2000) 56, 7 870-871
a=10.867(3)Å b=24.284(4)Å c=5.427(2)Å
α=90.00° β=90.00° γ=90.00°
Glycine sodium nitrate
C2H5NO2,NaNO3
Acta Crystallographica Section C (2001) 57, 10 1149-1150
a=14.329(3)Å b=5.2662(11)Å c=9.1129(18)Å
α=90° β=119.10(3)° γ=90°
4'-(2,4-Dichlorophenyl)-1,1'-dimethylpiperidine-3-spiro-3'- pyrrolidine-2'-spiro-3''-indoline-4,2''-dione
C23H23Cl2N3O2
Acta Crystallographica Section E (2010) 66, 3 o717
a=7.9398(2)Å b=10.8747(3)Å c=13.5367(4)Å
α=66.561(2)° β=77.8730(10)° γ=83.203(2)°
8-(2-Chlorophenyl)-1-(4-chlorophenyl)-4-[(<i>E</i>)-(2- chlorophenyl)methylidene]-6-methyl-4,5,6,7,7a,8-hexahydro- 1,2,4-oxadiazolo[5,4-<i>d</i>]pyrido[3,4-<i>c</i>][1,5]benzothiazepine
C33H26Cl3N3OS
Acta Crystallographica Section E (2010) 66, 5 o1119
a=11.015(3)Å b=11.758(4)Å c=11.988(4)Å
α=78.87(2)° β=86.89(3)° γ=78.29(2)°
2-Amino-4-(4-chlorophenyl)-5,6,7,8,9,10-hexahydrobenzo[8]annulene-1,3- dicarbonitrile
C20H18ClN3
Acta Crystallographica Section E (2012) 68, 9 o2692
a=11.3835(9)Å b=16.9840(13)Å c=18.4766(14)Å
α=90.00° β=90.00° γ=90.00°
[4-(2-Methoxyphenyl)-3-methyl-1-phenyl-6-trifluoromethyl-1<i>H</i>-pyrazolo[3,4-<i>b</i>]pyridin-5-yl](thiophen-2-yl)methanone
C26H18F3N3O2S
Acta Crystallographica Section E (2014) 70, 9 o974-o975
a=18.9343(11)Å b=11.6347(6)Å c=20.9800(12)Å
α=90° β=92.511(2)° γ=90°
4-Sulfamoylanilinium dihydrogen phosphate
C6H9N2O2S,H2O4P
Acta Crystallographica Section E (2014) 70, 9 o997-o998
a=4.8041(7)Å b=10.8564(15)Å c=10.3862(15)Å
α=90° β=101.067(2)° γ=90°